bluuebunny/crossref_metadata_2025_split huggingface dataset:
Abstract A067: Increasing risk of prostate cancer with successive generations in the US among Latino men in the Multiethnic Cohort
Authors: Chen Fei , Paik Adelynn , Sheng Xin , Cheng Iona , Shariff-Marco Salma , Wilkens Lynn R. , Le Marchand Loïc , Conti David V. , Haiman Christopher A. , Setiawan Veronica Wendy 
Published: September 2024

Abstract
This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR014) of the Conference Program/Proceedings.
Citation Format: Fei Chen, Adelynn Paik, Xin Sheng, Iona Cheng, Salma Shariff-Marco, Lynn R. Wilkens, Loïc Le Marchand, David V. Conti, Christopher A. Haiman, Veronica Wendy Setiawan. Increasing risk of prostate cancer with successive generations in the US among Latino men in the Multiethnic Cohort [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A067.
Abstract A072: Lung cancer survival disparities: A disaggregated AANHPI study of the SEER database
Authors: Doan Christopher Huy , Chen James , Wang Peter , Wang David , Mai Brian 
Published: September 2024

Abstract
Cancer is the overall leading cause of death in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) populations, with lung cancer specifically being the leading cause of cancer- related mortality. The AANHPI population has historically been treated as a "monolith" in scientific literature. However, an accurate understanding of AANHPI communities is needed to address disparities in cancer outcomes. Thus, it is necessary to analyze disaggregated data to identify unique factors and barriers for each unique subpopulation. Our study aims to explore lung cancer survival disparities between Asian American, Native Hawaiian, and Pacific Islander (AANHPI) subpopulations and non-Hispanic Whites (NHW) using SEER Research Data from 2000-2020. Cohorts were developed in order to disaggregate the AANHPI population. Due to the small sample size between nationalities, cohorts were grouped by geographical similarity. Cox regression analysis revealed a generally lower risk of death for AANHPI individuals compared to NHW. However, notable differences were observed within AANHPI subpopulations. South Asians demonstrate a 34.2% lower likelihood of lung cancer mortality compared to NHW, while East Asians show an 18.3% reduced risk. Native Hawaiian and Pacific Islanders saw similar survival, though it was not statistically significant. These disparities could indicate the influence of genetic, environmental, and lifestyle factors and differences in offered treatment on lung cancer prognosis. Our study highlights the importance of recognizing the diversity within AANHPI groups when assessing cancer risk and survival and the necessity for further investigation into the specific factors influencing survival differences. A more nuanced understanding will facilitate more targeted healthcare strategies to address the unique needs of each subpopulation.
Citation Format: Christopher Huy Doan, James Chen, Peter Wang, David Wang, Brian Mai. Lung cancer survival disparities: A disaggregated AANHPI study of the SEER database [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A072.
Abstract A073: Gut microbiome differences across race, ethnicity, and area level deprivation among patients undergoing colorectal cancer screening in Federally Qualified Health Centers
Authors: Hogue Stephanie , Gomez Maria F. , Xu Jin , Kim Youngchul , Veramendi Rosa , Fuentes Martha , Wetzler Carolina , Burns Jessica , Forsyth Sugriva , Abdulla Rania , Meade Cathy , Gwede Clement , Byrd Doratha A. 
Published: September 2024

Abstract
This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR009) of the Conference Program/Proceedings.
Citation Format: Stephanie Hogue, Maria F. Gomez, Jin Xu, Youngchul Kim, Rosa Veramendi, Martha Fuentes, Carolina Wetzler, Jessica Burns, Sugriva Forsyth, Rania Abdulla, Cathy Meade, Clement Gwede, Doratha A. Byrd. Gut microbiome differences across race, ethnicity, and area level deprivation among patients undergoing colorectal cancer screening in Federally Qualified Health Centers [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A073.
Abstract A092: Tobacco use and prevalence of oral premalignant lesions, among Malayali tribes, Yelagiri Hills, Tamil nadu, India
Authors: Francis Delfin Lovelina 
Published: September 2024

Abstract
BACKGROUND: India has the second largest tribal population of the world next to the African countries. About half of the world’s autochthonous people live in India, thus making India home to many tribes which have an interesting and varied history of origins, customs and social practices. The present study was conducted to assess the tobacco use and prevalence of precancerous lesions and oral cancer among Malayali tribes, Yelagiri Hills, Tamil nadu, India. METHODOLOGY The inhabitants of the 14 villages of the Yelagiri hills, who have completed 18years and residing for more than 15years present on the day of examination and who were willing to participate in the study were included. Data was collected from a cross-sectional survey, using a Survey Proforma, clinical examination and a pre-tested questionnaire. An intra-oral examination was carried out by a single examiner using WHO Oral Health Surveys – Basic Methods Proforma (1997). ResultsThe overall prevalence of smokeless and smoking tobacco was 78.8% and 65.2% respectively among 1550 study population. Of those who had the habit of smoking, 26% smoked beedi, 10.9% smoked cigarette, 65% chewed raw tobacco, 18% chewed Hans and 28% had a combination of smoking and smokeless tobacco usage. Around 49.8% of samples were stained positive for precancerous and cancerous lesions of the oral cavity. The highest number of positive samples were from buccal mucosa with 46.2% subjects and 12% for labial mucosa. The reason for practicing these habits were as a measure to combat the cold, relieving stress and body pain after work, and the lack of awareness of the hazards of the materials used. Prevalence of oral mucosal lesions in the study population was due to tobacco usage and alcohol consumption and lack of awareness regarding the deleterious effects of the products used. CONCLUSION Oral cancer is highly prevalent in this Malayali tribes owing to high tobacco consumption rates and habits warranting the cessation center a priority. Also, early detection and screening are vital to attaining better outcomes.
Citation Format: Delfin Lovelina Francis. Tobacco use and prevalence of oral premalignant lesions, among Malayali tribes, Yelagiri Hills, Tamil nadu, India [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A092.
Abstract A098: Lung cancer disparities among African Americans and other low-income communities in South Florida
Authors: Jordan Miles , Erwell Steven , Mwashote Ben , Mochona Bereket 
Published: September 2024

Abstract
Lung cancer is by far the leading cause of cancer death in the US, accounting for about 1 in 5 of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. The American Cancer Society estimates that in the US, in 2024, there will be about 234,580 new cases of lung cancer (116,310 in men and 118,270 in women). It estimates there will be around 125,070 deaths from lung cancer (65,790 in men and 59,280 in women). Though these deaths can mainly be attributed to smoking, environmental factors have also had adverse effects on human health and lung cancer. We see an example of this in Florida with agricultural burning, specifically sugarcane burning. Sugarcane is one of the most important cash crops for Florida, around 10% of sugar produced in the United States comes from Florida. However, despite the economic importance of this crop, its harvesting process is controversial creating air pollution that is having adverse health effects on the surrounding communities. This review will discuss the impact of sugarcane burning on African Americans and other low-income communities, and how it’s exacerbating health issues, specifically lung cancer. As well as suggest better alternatives to sugarcane harvesting.
Citation Format: Miles Jordan, Steven Erwell, Ben Mwashote, Bereket Mochona. Lung cancer disparities among African Americans and other low-income communities in South Florida [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A098.
Abstract A117: Cervical cancer screening rates among older Hispanic women living in Texas: results using the BRFSS 2018, 2020, and 2022 survey data
Authors: Vázquez-Otero Coralia , Elewonibi Bilikisu , Ankwe Adaobi , BeLue Rhonda 
Published: September 2024

Abstract
Background: Despite cancer risk increasing with age, older women are less likely to be up-to- date with cervical cancer screening (CCS). CCS is recommended up-to 65 years, absent history of abnormal results. CCS rates are significantly lower among Hispanic women, despite higher cervical cancer incidence and mortality rates compared to non-Hispanic white women. In Texas, women older than 50 years have lower odds of timely pap testing. We examined CCS rates among older Hispanic women in Texas using data from the Behavioral Risk Factor Surveillance System. Methods: Our sample included 5,291 self-identified Hispanic women, ages 50-64. Outcome: receipt of pap smear within the last 3 years following the U.S. Preventive Services Task Force guidelines at the time each survey was conducted (years: 2018, 2020 and 2022). Descriptive analysis and chi-square tests were used to examine the proportion of women who reported receiving CCS within the recommended timeframe. Results: Only 63.75% (mean age = 56.4) reported getting a pap smear. Significant decreases were found among women who had a pap smear from 87.03% in 2018, 71.95% in 2020, and 43.24% in 2022 (p=0.00). Additional analyses will be conducted to test relationships with sociodemographic and healthcare variables. Conclusion: Older Hispanic women in Texas represented in this dataset are far from the 2030 Healthy People goal of 79% CCS. Decreases in CCS rates are possibly due to the COVID-19 pandemic impact on healthcare access. As the US population ages, research is needed to identify the potential systemic barriers this group is confronting to access preventive cancer care.
Citation Format: Coralia Vázquez-Otero, Bilikisu Elewonibi, Adaobi Ankwe, Rhonda BeLue. Cervical cancer screening rates among older Hispanic women living in Texas: results using the BRFSS 2018, 2020, and 2022 survey data [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A117.
Abstract B003: Inclusion of deaf, deafblind, and hard of hearing people in cancer clinical trials: Innovative accessible technologies
Authors: Kushalnagar Poorna , Kushalnagar Raja 
Published: September 2024

Abstract
We present an innovative informed consent app designed for deaf, deafblind, and hard of hearing people who use sign language and wish to participate in clinical trial studies. The informed consent process on the accessible app displays each section of informed consent form in sign language and captures the participant’s signed responses through a mobile device camera. If the response in sign language is “yes” or “I consent”, the app captures the response and moves on to the next step. Participants can also respond in sign language with “no” or “repeat” if they did not understand the a specific section in the informed consent document on the app. The app also supports recording the participants’ signature in sign language instead of English if they desire to do so. Feedback from diverse deaf, deafblind, and hard of hearing signers, including college students, senior citizens and people of color, showed that the app supporting the interactive informed consent process is culturally and linguistically appropriate for diverse people who have sensory disabilities and rely on primarily sign language. The accessible informed consent app also gives people with sensory disabilities greater autonomy as research participants in clinical trials as well as assists researchers in reducing the barriers that often prevent sign language users from participating in clinical trial studies. This study was funded by the National Library of Medicine/NIH.
Citation Format: Poorna Kushalnagar, Raja Kushalnagar. Inclusion of deaf, deafblind, and hard of hearing people in cancer clinical trials: Innovative accessible technologies [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B003.
Abstract B087: Inflammation and breast cancer: Understanding the interplay and implications for prevention and treatment
Authors: Ogungbola Opeyemi O. , Ejeh Samuel O. , Odeh Jane , Omoniyi Olajumoke R. , Akomolafe Abayomi A. , Abudu Emmanuel K. 
Published: September 2024

Abstract
Breast cancer continues to be a major global health issue, affecting millions and posing challenges for researchers and healthcare workers. Recent research has revealed the importance of inflammation in the development and progression of a variety of malignancies, including breast cancer. The aim of this study is to investigate the complex association between inflammation and breast cancer in order to improve treatment and preventative techniques. A mixed-methods approach was used, with both quantitative and qualitative studies. The study included 580 breast cancer patients and 2,573 control participants. Patient records, hospital databases, and publicly available datasets were all used as data sources. Statistical methods, including univariate and multivariate logistic regression models, were employed to discover breast cancer predictors associated with inflammation. Breast cancer growth is strongly linked to chronic inflammation and specific inflammatory markers (CRP, IL-6, and TNF-α). Breast cancer incidence is correlated with geographical, demographic, and lifestyle characteristics such as region, age, gender, race, education level, and overall health condition. Comorbidities like hypertension, diabetes, and arthritis, as well as BMI, smoking, and physical activity levels, all have a role in risk. Anti-inflammatory drugs and lifestyle changes show promise for lowering the risk of breast cancer and improving patient outcomes. The study reveals significant relationships between breast cancer incidence and a variety of demographic, lifestyle, and health-related variables. Chronic inflammation is important in the development of breast cancer; therefore, inflammatory indicators could be used as diagnostic or therapeutic tools. The study suggests that tailored anti-inflammatory medications and lifestyle changes could have a significant impact on breast cancer prevention and therapy. This study emphasizes the necessity of knowing the relationship between inflammation and breast cancer. The insights revealed can lead to novel methods for breast cancer management, stressing the importance of ongoing research to fully understand the connection between inflammation and breast cancer and to implement these discoveries in clinical practice.
Citation Format: Opeyemi O. Ogungbola, Samuel O. Ejeh, Jane Odeh, Olajumoke R. Omoniyi, Abayomi A. Akomolafe, Emmanuel K. Abudu. Inflammation and breast cancer: Understanding the interplay and implications for prevention and treatment [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B087.
Abstract B093: Facilitating conversations on cancer genomic education: Development of a toolkit for community advisory boards
Authors: Whitted Calandra G. 
Published: September 2024

Abstract
Community Advisory Boards are representative groups of individuals that reside in a particular area and serve an important role in the research process. Often CABs are the voice of the community, rather it be key community stakeholders, business, or community organizations. The purpose of this project is to describe the development of a cancer genomic toolkit and initial introduction of the toolkit to local community advisory boards to CAB members interested in cancer genomic topics to increase inclusion and awareness of emerging topics and activities around cancer genomic research. Existing CAB members from the Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State University Cancer Partnership (MVTCP) and the Research Centers in Minority Institutions (RCMI) at Meharry Medical College were introduced to a cancer genomic toolkit that is in development. CAB members were presented the toolkit during a regularly scheduled CAB meeting for approximately 30 minutes and were allowed 10 minutes to answer questions. After the presentation of the cancer genomic toolkit, CAB members were sent a word document version of the toolkit to provide any feedback for improvement during the development stage. CAB members were allowed up to two months to review the cancer genomic toolkit. Directions for review were to use track changes and leave comments or provide direct feedback via email response. To date, one CAB member has provided individualized feedback. Group feedback included questions and open discussion around historic research participation. Next steps are to introduce the tool to a newly formed genomic community advisory board and begin to reiterate the toolkit for evaluation and implementation for other local CABs.
Citation Format: Calandra G. Whitted. Facilitating conversations on cancer genomic education: Development of a toolkit for community advisory boards [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B093.
Abstract B105: Quality and Accessibility of Online Information Regarding CAR-T Therapy in Hematologic Malignancies
Authors: Garcia Luis C. , Velázquez Ana I. 
Published: September 2024

Abstract
Background Chimeric antigen receptor T-cell (CAR-T) therapies have changed the treatment landscape for various hematologic malignancies and are currently under development and being tested in clinical trials for multiple solid tumors. Given that patients commonly use the internet as a source of health-related information, we sought to investigate the quality, understandability, and readability of online information regarding CAR-T therapy. Methods We conducted a search in a commonly used search engine (Google) of five pre-determined search terms to identify 100 unique web pages regarding CAR-T therapy. Scientific publications were excluded. Validated instruments were used to ascertain health information quality (DISCERN), understandability (Patient Education Materials Assessment Tool; PEMAT), and readability (Flesch-Kincaid, Gunning Fog, and SMOG indices). Results were summarized using descriptive statistics. Results Among the 100 web pages reviewed, 68% originated from academic medical centers, and 64% included links to clinical trials. Only 11% of the web pages included references to primary literature. 17% of web pages were available in a language other than English, with Spanish (15%) and Arabic (7%) being the most common. Moderate-to-high quality information (DISCERN ≥ 3) was presented by 47% of web pages, and only 31% of web pages were considered understandable (PEMAT ≥ 70%). Average readability scores were 10.6 (SD = 2.09), 12.6 (SD = 2.3), and 13.1 (SD = 1.7) using the Flesch-Kincaid, Gunning Fog, and SMOG indices, respectively. Conclusion Our study highlights that online information for CAR-T therapies commonly features low-quality health information that is typically not understandable to the general population. Further, contrary to recommendations from federal agencies and medical societies, available online information requires, on average, high school reading comprehension. Healthcare teams and stakeholders should strive to improve existing content and ensure patients have access to trusted, high-quality information given the unique complexities, processes, and toxicities associated with receiving CAR-T therapy.
Citation Format: Luis C. Garcia, Ana I. Velázquez. Quality and Accessibility of Online Information Regarding CAR-T Therapy in Hematologic Malignancies [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B105.